Author name: Tim Devlin

Improving access to medicines

A new WHO report provides insight into how countries in the WHO European Region can improve access and reduce medicine prices through strategic and well-planned procurement processes. It also addresses collaboration within and across countries to improve availability of affordable medicines for patients in the Region. Countries in the Region have varying capacity and negotiating […]

Improving access to medicines Read More »

Sun-beds – no safe limit for UVR exposure

The final Opinion on the biological effects of ultraviolet radiation relevant to health with particular reference to sunbeds for cosmetic purposes has been published by the European Commission and its Scientific Committee on Health, Environmental and Emerging Risks (SCHEER). Ultraviolet Radiation (UVR), including that emitted by sunbeds, is considered a complete carcinogen, in that it

Sun-beds – no safe limit for UVR exposure Read More »

HIV & Hepatitis in Europe

There are 53 countries in the WHO European Region and within those countries there are 15 million people living with hepatitis C and 13.3 million people living with hepatitis B, the vast majority of whom are unaware of their infection and therefore at risk of developing cirrhosis or liver cancer. On average, fewer than 3{ddf8d179d1bf712bb2a88ff2ad95ebdf63eaa5463c845d2f093b25848387ba96}

HIV & Hepatitis in Europe Read More »

Scroll to Top